SVA 0.00% 2.2¢ simavita limited

Ann: Lorien Health Systems in US to roll out SIM, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,085 Posts.
    lightbulb Created with Sketch. 24
    The Lorien contract is certainly a good start. The actual amount SVA will receive I think will be quite low. The interesting feature about Lorien was that it was already a Medline customer.

    Broker figures are rarely correct. They do sometimes have access to additional data and are prepared to talk to the researched company's partners in order to get a clearer picture of the potential. Edison's DCF valuation of $107m gives a share price of ~$1.46. There must be some very good numbers down the track a bit. They need to expand their spreadsheet in the report to cover another 5 or so years.

    Edison also used a A$1.08 : US$1 whereas it is now A$1.15 to the US$ and (apparently) with further to fall.

    My holding in SVA is quite low at 1.8% of my share investment account. It is not on the MLC list of allowed shares for my super. I am comfortable with this level of exposure and prepared to let it sit. There is always the possibility of a takeover from Medline.

    I have 2 other companies in similar situations - NAN and IPD. Both are a bit more advanced and with enough cash to keep them happy.

    The SVA 1st Qtr report will be interesting and if excellent, I will certainly add to my holding. But I think it will probably take until the 2nd Qtr before we can get some idea of the potential of SVA.
 
watchlist Created with Sketch. Add SVA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.